Knockout serum replacement promotes cell survival by preventing BIM from inducing mitochondrial cytochrome c release

Yuki Ishii, May Keu Nhiayi, Edison Tse, Jonathan Cheng, Michele Massimino, Donald L. Durden, Paolo Vigneri, Jean Y.J. Wang

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Knockout serum replacement (KOSR) is a nutrient supplement commonly used to replace serum for culturing stem cells. We show here that KOSR has pro-survival activity in chronic myelogenous leukemia (CML) cells transformed by the BCR-ABL oncogene. Inhibitors of BCR-ABL tyrosine kinase kill CML cells by stimulating pro-apoptotic BIM and inhibiting antiapoptotic BCL2, BCLxL and MCL1. We found that KOSR protects CML cells from killing by BCR-ABL inhibitors-imatinib, dasatinib and nilotinib. The protective effect of KOSR is reversible and not due to the selective outgrowth of drug-resistant clones. In KOSR-protected CML cells, imatinib still inhibited the BCR-ABL tyrosine kinase, reduced the phosphorylation of STAT, ERK and AKT, down-regulated BCL2, BCLxL, MCL1 and up-regulated BIM. However, these pro-apoptotic alterations failed to cause cytochrome c release from the mitochondria. With mitochondria isolated from KOSR-cultured CML cells, we showed that addition of recombinant BIM protein also failed to cause cytochrome c release. Besides the kinase inhibitors, KOSR could protect cells from menadione, an inducer of oxidative stress, but it did not protect cells from DNA damaging agents. Switching from serum to KOSR caused a transient increase in reactive oxygen species and AKT phosphorylation in CML cells that were protected by KOSR but not in those that were not protected by this nutrient supplement. Treatment of KOSR-cultured cells with the PH-domain inhibitor MK2206 blocked AKT phosphorylation, abrogated the formation of BIM-resistant mitochondria and stimulated cell death. These results show that KOSR has cell-context dependent pro-survival activity that is linked to AKT activation and the inhibition of BIM-induced cytochrome c release from the mitochondria.

Original languageEnglish (US)
Article numbere0140585
JournalPloS one
Volume10
Issue number10
DOIs
StatePublished - Oct 16 2015

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint Dive into the research topics of 'Knockout serum replacement promotes cell survival by preventing BIM from inducing mitochondrial cytochrome c release'. Together they form a unique fingerprint.

  • Cite this

    Ishii, Y., Nhiayi, M. K., Tse, E., Cheng, J., Massimino, M., Durden, D. L., Vigneri, P., & Wang, J. Y. J. (2015). Knockout serum replacement promotes cell survival by preventing BIM from inducing mitochondrial cytochrome c release. PloS one, 10(10), [e0140585]. https://doi.org/10.1371/journal.pone.0140585